Immunization, HepB3 in Early-demographic dividend

Early-demographic dividend: Immunization, HepB3 was 86.7% in 2024. ◆ Volatile

Latest (2024)
86.7%
Change on year
up 0.2%
Rank
20th
of 47 groups
All-time high
87.3%
in 2022
All-time low
0.0%
in 1985
Years of data
40
1985–2024

Immunization, HepB3 in Early-demographic dividend, 1985–2024

0204060801985200420241985: 0 % of one-year-old children1986: 0 % of one-year-old children1987: 0 % of one-year-old children1988: 0 % of one-year-old children1989: 0.003 % of one-year-old children1990: 0.475 % of one-year-old children1991: 0.608 % of one-year-old children1992: 3 % of one-year-old children1993: 4.2 % of one-year-old children1994: 7.7 % of one-year-old children1995: 10.3 % of one-year-old children1996: 11.7 % of one-year-old children1997: 13.5 % of one-year-old children1998: 14.5 % of one-year-old children1999: 15.3 % of one-year-old children2000: 19.9 % of one-year-old children2001: 21.7 % of one-year-old children2002: 24.4 % of one-year-old children2003: 32.1 % of one-year-old children2004: 37.1 % of one-year-old children2005: 42.3 % of one-year-old children2006: 45.5 % of one-year-old children2007: 49.8 % of one-year-old children2008: 59.8 % of one-year-old children2009: 63.9 % of one-year-old children2010: 64.5 % of one-year-old children2011: 67.4 % of one-year-old children2012: 77.6 % of one-year-old children2013: 77.1 % of one-year-old children2014: 81.2 % of one-year-old children2015: 84.3 % of one-year-old children2016: 85.9 % of one-year-old children2017: 85.2 % of one-year-old children2018: 85.5 % of one-year-old children2019: 86.2 % of one-year-old children2020: 82.6 % of one-year-old children2021: 81.3 % of one-year-old children2022: 87.3 % of one-year-old children2023: 86.5 % of one-year-old children2024: 86.7 % of one-year-old children

Source: World Health Organization (WHO). Measured in % of one-year-old children.

Analysis

Early-demographic dividend recorded 86.7% for immunization, hepb3 in 2024.

Compared with earlier readings it is up 0.2% on the previous year and up 6.7% over ten years.

Over the whole period, immunization, hepb3 in Early-demographic dividend peaked at 87.3% in 2022 and was at its lowest, 0.0%, in 1985.

Early-demographic dividend ranks 20th of 47 groups on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Immunization, HepB3 in Early-demographic dividend, year by year

Annual values for Immunization, HepB3 (% of one-year-old children) in Early-demographic dividend, 1985 to 2024.
Year % of one-year-old children Change
1985 0.0%
1986 0.0%
1987 0.0%
1988 0.0%
1989 0.0%
1990 0.5% +17626.7%
1991 0.6% +28.1%
1992 3.0% +392.7%
1993 4.2% +41.4%
1994 7.7% +82.1%
1995 10.3% +33.2%
1996 11.7% +13.9%
1997 13.5% +15.1%
1998 14.5% +7.8%
1999 15.3% +5.1%
2000 19.9% +30.6%
2001 21.7% +8.9%
2002 24.4% +12.4%
2003 32.1% +31.4%
2004 37.1% +15.7%
2005 42.3% +14.0%
2006 45.5% +7.6%
2007 49.8% +9.4%
2008 59.8% +20.1%
2009 63.9% +6.8%
2010 64.5% +1.0%
2011 67.4% +4.4%
2012 77.6% +15.2%
2013 77.1% -0.7%
2014 81.2% +5.4%
2015 84.3% +3.9%
2016 85.9% +1.8%
2017 85.2% -0.8%
2018 85.5% +0.4%
2019 86.2% +0.8%
2020 82.6% -4.2%
2021 81.3% -1.6%
2022 87.3% +7.3%
2023 86.5% -0.8%
2024 86.7% +0.2%

Averages by decade

DecadeAverage LowestHighest Years
1980s 0.0% 0.0% 0.0% 5
1990s 8.1% 0.5% 15.3% 10
2000s 39.7% 19.9% 63.9% 10
2010s 79.5% 64.5% 86.2% 10
2020s 84.9% 81.3% 87.3% 5

Countries ranked near Early-demographic dividend

  1. 19 Belarus 98.0% compare
  2. 19 Bhutan 98.0% compare
  3. 19 Guyana 98.0% compare
  4. 19 Iran, Islamic Republic of 98.0% compare
  5. 19 Kazakhstan 98.0% compare
  6. 19 Luxembourg 98.0% compare
  7. 19 Rwanda 98.0% compare

See the full ranking of 235 places →

More health data for Early-demographic dividend

All data for Early-demographic dividend →

Frequently asked questions

What is immunization, hepb3 in Early-demographic dividend?
Immunization, hepb3 in Early-demographic dividend was 86.7% in 2024, according to World Health Organization (WHO).
What is the highest immunization, hepb3 recorded in Early-demographic dividend?
The highest recorded value was 87.3% in 2022.
What is the lowest immunization, hepb3 recorded in Early-demographic dividend?
The lowest recorded value was 0.0% in 1985.
How does Early-demographic dividend rank for immunization, hepb3?
Early-demographic dividend ranks 20th out of 47 groups with data for 2024.
Is immunization, hepb3 rising or falling in Early-demographic dividend?
Over the last ten years it is up 6.7%. The long-run trend across the full record is volatile.
Where does this Early-demographic dividend data come from?
The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Immunization, HepB3 in Early-demographic dividend. Statizoid, drawing on World Health Organization (WHO). Retrieved 09 September 2026, from https://health.statizoid.com/stat/immunization-hepb3-percent-of-one-year-old-children/early-demographic-dividend/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/immunization-hepb3-percent-of-one-year-old-children/early-demographic-dividend/">Immunization, HepB3 in Early-demographic dividend</a> — Statizoid

About this data

Indicator
Immunization, HepB3 (% of one-year-old children)
Unit
% of one-year-old children
Source
World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 6,534 data points, 1985–2024
Last refreshed

Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.